Clinical Trials Browser

Phase 1/2 × Terminated × bicalutamide × Clear all

NCT00924807 2018-12-11

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Phase 1/2 Terminated

4 enrolled 4 charts

Prostatic Neoplasms

NCT01020305 2014-10-13

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Phase 1/2 Terminated

5 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms